Agenda
3:00 PM - 3:30 PM    Registration and Networking
3:30 PM - 5:00 PM    Industry Panel
5:00 PM - 6:30 PM    Networking Reception

Effectively raising capital is crucial for any company. Although VC's are a traditional source of funds, there are many opportunities for financing that can get your company to where you need it to be. You just need to know the right people.

Join our panel to hear from private wealthy individuals, government granting agencies, foundations, angels and VCs who have opportunities for you to fund your company.

Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Networking Reception.

Speakers | Partial List
� Kurt A. Henry, MD, Biological Defense Research Directorate, US Naval Medical Research Center, DOD
� Guy Miller MD, PhD, Chairman & CEO, Edison Pharmaceuticals


Cost & Registration
� Regular Price: $60
� Partners' Network: $50
� BioCenter Members: Free (please RSVP to Aur�lie)
� On-site Registration: add $10 to the above
This event is typically sold out, so early pre-registration is recommended to avoid disappointment on the day!

Register to the full 2010 Industry Panel Series and save!
Full Panel Series registration includes access to:
� How to Become a VC Magnet? | Mar. 25
� Financing Alternatives | Jun. 3
� Doing Deals with Big Pharma | Sep. 23
� 6th Annual Trends in Financing Investor Panel & Holiday Celebration | Dec. 9

Venue
Orrick, Herrington & Sutcliffe LLP
1000 Marsh Road
Building 1100
Menlo Park, CA 94025-1015
Click here for Venue Directions»


Speakers Bios

Guy Miller MD, PhD, Chairman & CEO, Edison Pharmaceuticals
Guy Miller, MD, PhD, is the Chairman and Chief Executive Officer of Edison Pharmaceuticals. He holds a clinical faculty appointment at Stanford University School of Medicine/PAVAMC, in medical-surgical critical care and is an Adjunct Professor, University of North Carolina, School of Public Health. Prior to Edison, he founded Galileo Pharmaceuticals, and was its Chairman and CEO from 1995-2005. Dr. Miller completed a surgical internship at the University of Chicago and residency and fellowship in anesthesiology & critical care medicine at Johns Hopkins, where he was an Assistant Professor until 1995.
Edison has obtained substantial non-dilutive peer-reviewed grant support to advance both its pre-clinical and clinical initiatives from foundations including the Muscular Dystrophy Association, Friedreich's Ataxia Research Alliance, and Seek A Miracle. The company closed Series A Preferred Stock Offering in November 2005, and Series B Financing led by Mr. Carl Berg, Berg & Berg Enterprises, LLC. New investors included John W. Marriott, III, President and CEO of JWM, LP, and JWM Family Enterprises.